Invention Grant
US07709473B2 Substituted 2H-[1,2,4]triazolo[4,3-a]pyrazines as GSK-3 inhibitors
失效
取代的2H- [1,2,4]三唑并[4,3-a]吡嗪作为GSK-3抑制剂
![Substituted 2H-[1,2,4]triazolo[4,3-a]pyrazines as GSK-3 inhibitors](/docs/US/2010-05-04/US07709473B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted 2H-[1,2,4]triazolo[4,3-a]pyrazines as GSK-3 inhibitors
- Patent Title (中): 取代的2H- [1,2,4]三唑并[4,3-a]吡嗪作为GSK-3抑制剂
-
Application No.: US10575395Application Date: 2004-09-27
-
Publication No.: US07709473B2Publication Date: 2010-05-04
- Inventor: John William Benbow
- Applicant: John William Benbow
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Agent Gregg C. Benson; John A. Wichtowski
- International Application: PCT/IB2004/003137 WO 20040927
- International Announcement: WO2005/035532 WO 20050421
- Main IPC: A61K31/54
- IPC: A61K31/54 ; A61K31/535 ; A61K31/497 ; A61K31/505 ; C07D417/00 ; C07D413/00 ; C07D403/00 ; C07D239/02
![Substituted 2H-[1,2,4]triazolo[4,3-a]pyrazines as GSK-3 inhibitors](/abs-image/US/2010/05/04/US07709473B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to compounds of formula (I) prodrugs thereof, and the pharmaceutically acceptable salts of the compounds and prodrugs, wherein Ra, Rb, R1 and R2 are as defined herein; pharmaceutical compositions thereof; and uses thereof.
Public/Granted literature
- US20070249612A1 Substituted 2H-[1,2,4]Triazolo[4,3-A]Pyrazines as Gsk-3 Inhibitors Public/Granted day:2007-10-25
Information query
